Skip to main navigation Skip to search Skip to main content

Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis

  • Michael Benatar
  • , Eric A. Macklin
  • , Andrea Malaspina
  • , Mary Louise Rogers
  • , Eran Hornstein
  • , Vittoria Lombardi
  • , Danielle Renfrey
  • , Stephanie Shepheard
  • , Iddo Magen
  • , Yahel Cohen
  • , Volkan Granit
  • , Jeffrey M. Statland
  • , Jeannine M. Heckmann
  • , Rosa Rademakers
  • , Caroline A. McHutchison
  • , Leonard Petrucelli
  • , Corey T. McMillan
  • , Joanne Wuu
  • , CReATe Consortium PGB1 Study Investigators

Research output: Contribution to journal › Article › peer-review

48 Citations (Scopus)
49 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology